Healthcare -
Biotechnology - NASDAQ - US
$ 0.884
1.03 %
$ 69.2 M
Market Cap
5.53
P/E
CTMX - GROSS PROFIT
Gross Profit CTMX - CytomX Therapeutics, Inc.
101 M
LAST VALUE
26.02%
2 YEAR CAGR
11.21%
5 YEAR CAGR
60.58%
10 YEAR CAGR